He also holds the Wolfe Medical Research Chair in Pharmacogenomics at Western. He has been actively leading a program of excellence in Personalized Medicine. In 2008, he started the first personalized medicine clinic in Canada and since 2011, personalized medicine inpatient consultation service has been available for patients who are at risk for toxicity or subtherapeutic benefit from a number of drugs in clinical use whether for children or the elderly, for cardiovascular disease, inflammatory conditions, and cancer. He is an elected Member of the American Society for Clinical Investigation (ASCI) and Fellow of the American Association of Pharmaceutical Scientists (AAPS) and Canadian Academy of Health Sciences (CAHS).